- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04538612
DiCART TM Device for Capillary Refill Time Measurement (DICART-VS)
DiCART TM Device for Capillary Refill Time Measurement : a Validation Study.
To estimate peripheral perfusion in shock state, international guidelines recommend the use of capillary refill time, and practitioners currently evaluates it at bedside. However its measurement is not standardized, what should explain the large observer variability reported in different studies. Hence, a device providing a standardized evaluation seems to be helpful.
The aim of the study is to evaluate diagnostic performance of such a device recently developped (DiCART TM), in healthy volunteers experiencing vascular occlusion tests to induce impaired perfusion.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bron, France
- Hospital Louis Pradel
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy volunteers
- Age > 18 years old
- Informed consent to participate
Exclusion Criteria:
- Vascular disease
- Diabetes mellitus
- Dermatosis
- Cutaneous lesion on a measurement site
- Anemia
- Pregnancy
- Cardiovascular chronic treatment
- Non affiliation to a social security regime
- Involvement in other interventional study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: measure capillary refill time
|
Each time, capillary refill time will be evaluated three times consecutively by clinical method applying a firm pressure with the finger during 15s, then brutally releasing it, and estimating time of skin recoloration with a chronometer and by DiCART TM device Three vascular occlusion tests will be successively performed with a cuff during less than 10 minutes:
Randomization determine the order of the vascular occlusion tests. Investigators performing capillary refill time evaluation will be blinded from it. Vascular occlusion tests will be alternatively performed by one and the other limb. The whole protocol will be performed at the upper and then at the lower limb. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Capillary refill time on the thenar eminence evaluated with DiCART TM device.
Time Frame: 180 minutes
|
Diagnostic performance of DiCART TM device to detect a capillary refill time variation on the thenar eminence induced by a vascular occlusion test on the arm. DiCART TM measurement is fully automatized, and may be separated in three consecutive step :
|
180 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Capillary refill time evaluated on the knee with DiCART TM device
Time Frame: 180 minutes
|
Diagnostic performance of DiCART TM device to detect a capillary refill time variation on the knee induced by a vascular occlusion test on the leg DiCART TM measurement is fully automatized, and may be separated in three consecutive step :
|
180 minutes
|
Intra -observer variability of capillary refill time measurement with DiCART TM device by performing repetitive measurements by two different investigators.
Time Frame: 180 minutes
|
Two different investigators will realize 5 measurements of capillary refill time with DiCART TM device and standard clinical method in physiological conditions in two different sites (knee and thenar eminence).
We will compute least significant change and standard deviation/mean ratio to evaluate observer variability.
|
180 minutes
|
Intra -observer variability of capillary refill time measurement with clinical method by performing repetitive measurements by two different investigators.
Time Frame: 180 minutes
|
Two different investigators will realize 5 measurements of capillary refill time with DiCART TM device and standard clinical method in physiological conditions in two different sites (knee and thenar eminence).
We will compute least significant change and standard deviation/mean ratio to evaluate observer variability.
|
180 minutes
|
Inter-observer variability of capillary refill time measurement with DiCART TM device by performing repetitive measurements by two different investigators.
Time Frame: 180 minutes
|
Two different investigators will realize 5 measurements of capillary refill time with DiCART TM device and standard clinical method in physiological conditions in two different sites (knee and thenar eminence).
We will compute least significant change and standard deviation/mean ratio to evaluate observer variability.
|
180 minutes
|
Inter-observer variability of capillary refill time measurement with clinical method by performing repetitive measurements by two different investigators.
Time Frame: 180 minutes
|
Two different investigators will realize 5 measurements of capillary refill time with DiCART TM device and standard clinical method in physiological conditions in two different sites (knee and thenar eminence).
We will compute least significant change and standard deviation/mean ratio to evaluate observer variability.
|
180 minutes
|
Capillary refill time variation induced by vascular occlusion test on the knee with DiCART TM device
Time Frame: 180 minutes
|
Standard clinical measurement is realized by applying a firm pressure with the finger during 15s and by brutally releasing it.
Then, skin recoloration is evaluated visually with a chronometer.
|
180 minutes
|
Capillary refill time variation induced by vascular occlusion test on the knee with standard clinical method
Time Frame: 180 minutes
|
Standard clinical measurement is realized by applying a firm pressure with the finger during 15s and by brutally releasing it.
Then, skin recoloration is evaluated visually with a chronometer.
|
180 minutes
|
Capillary refill time variation induced by vascular occlusion test on the thenar eminence with DiCART TM device .
Time Frame: 180 minutes
|
Standard clinical measurement is realized by applying a firm pressure with the finger during 15s and by brutally releasing it.
Then, skin recoloration is evaluated visually with a chronometer.
|
180 minutes
|
Capillary refill time variation induced by vascular occlusion test on the thenar eminence with standard clinical method.
Time Frame: 180 minutes
|
Standard clinical measurement is realized by applying a firm pressure with the finger during 15s and by brutally releasing it.
Then, skin recoloration is evaluated visually with a chronometer.
|
180 minutes
|
Capillary refill time measured by mathematical algorithms
Time Frame: 180 minutes
|
After the experimental phase, the investigators will develop mathematical algorithms to optimize video data interpretation.
|
180 minutes
|
number of patients with cutaneous lesions
Time Frame: 180 minutes
|
To evaluate the safety of DiCART TM device
|
180 minutes
|
Pain evaluation assessed by numeric rating scale
Time Frame: 180 minutes
|
Pain scale (minimum 1 to maximum 10), 1=No pain,10=Unbearable pain
|
180 minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Matthias JACQUET-LAGREZE, MD, Hospices Civils de Lyon
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 69HCL18_0217
- 2019-A00094-53 (Other Identifier: IDRCB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peripheral Perfusion
-
Assiut UniversityRecruiting
-
Assiut UniversityCompleted
-
Nihon KohdenTerminated
-
Terumo Medical CorporationMedical University of South CarolinaCompleted
-
National University of Natural MedicineCompletedPeripheral Perfusion | Skin Oxygenation
-
Erzincan UniversityUnknownPerfusion Index | Peripheral Nerve Block Success
-
Inonu UniversityNot yet recruitingPerfusion; Complications | Arterial Catheterization, Peripheral
-
University Hospital Inselspital, BerneCompletedPeripheral PerfusionSwitzerland
-
Rigshospitalet, DenmarkRadiometer Medical ApSCompletedMicrocirculation | Peripheral Perfusion | Transcutaneous Monitoring | Tissue MetabolismDenmark
-
Cairo UniversityUnknownPeripheral Perfusion IndexEgypt
Clinical Trials on measure capillary refill time
-
Hospices Civils de LyonCompleted
-
Oregon Health and Science UniversityCompleted
-
Oregon Health and Science UniversityRecruiting
-
Nihon KohdenCompleted
-
Hôpital Necker-Enfants MaladesUniversity Hospital, Strasbourg, France; Poitiers University Hospital; University... and other collaboratorsUnknownShock, Septic | Shock, HemorrhagicFrance
-
Medical University of SilesiaRecruitingCritical IllnessPoland
-
Nihon KohdenTerminated
-
Massachusetts Institute of TechnologyBoston Children's Hospital; National Institutes of Health (NIH); National Institute...CompletedDehydrationUnited States
-
University Hospital, ToulouseCompleted
-
Seoul National University HospitalDS MAREF Co., Ltd.; Small and Medium Business Administration, KOREACompletedVenous Thrombosis | Deep Vein ThrombosisKorea, Republic of